1. President Trump readying drug pricing executive orders — Roche Tecentriq-Avastin combo fails to hit primary endpoint in ovarian cancer trial — Moderna's COVID vaccine could see $5B or more in sales, say analysts — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Bydureon - Here is the truth

Discussion in 'Amylin' started by Anonymous, Jan 27, 2012 at 5:26 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Are you kiddin' me? Drs will push this system because they will get to bill for those small surgeries.

  2. anonymous

    anonymous Guest

    Nice try. Nausea was 2% in the studies. This product is a game changer and you dont even know yet what minor surgery procedure will cost. Patients will want it and so will primary care docs so they can control compliance. Managed care will love too because a compliant patient doesnt go to hospital. 1 hospital admission saved pays for.hundreds of patients to get product. Its a no brainer.
  3. anonymous

    anonymous Guest

    The time of launch is NEVER...sorry.
  4. My sources say NO...what are smoking. Plus increase risk for pancreatic cancer, all for ~1.2 A1c drop get real numnuts!